Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review
Meta-analysis / review
Abstract
This review summarises the potential of rosemary (Rosmarinus officinalis, = Salvia rosmarinus) as a therapeutic plant in metabolic syndrome, covering its antioxidant, anti-inflammatory, hypoglycaemic and hypolipidemic effects.
Referenced for these plants
How to cite
Hassani, F.V., Shirani, K. and Hosseinzadeh, H (2016) 'Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review', Naunyn-Schmiedeberg's Archives of Pharmacology, 389(9), pp. 931-949. doi:10.1007/s00210-016-1256-0
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.